Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Preliminary results reported for lisofylline in acute myeloid leukemia phase II trial

July 17, 1997

Final dosimetry analysis of phase II/III trial of Oncolym

July 17, 1997

Cell Pathways reports chemoprotective activity of sulindac sulfone in animal model

July 17, 1997

Survival rates after radical prostatectomy estimated

July 16, 1997

Peptidomimetic protein farnesyltransferase inhibitors from Merck & Co.

July 16, 1997

Cholecalciferols for leukemia prepared at Roche

July 16, 1997

Roussel Uclaf describes antiandrogenic compounds

July 16, 1997

Parke-Davis protein tyrosine kinase inhibitor has multiple activities

July 16, 1997

Vitamin B12 depletion reported to induce apoptosis

July 15, 1997

ICRF-187 for preventing anthracycline cardiotoxicity in children

July 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.